CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Pharmacia Corporation is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Pharmacia Corporation
100 Route 206 North
Phone: (908) 901-8000p:908 901-8000 Peapack, NJ  07977  United States Ticker: PHA PHA
This company was Merged or Acquired on 4/6/2003.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company
Business Summary
Pharmacia Corporation is primarily involved in the development, manufacturing and sale of pharmaceutical products. Prescription pharmaceuticals is the Company's only business segment and includes general therapeutics, ophthalmology and hospital products, including oncology and diversified therapeutics. The Company also operates several business units that do not constitute reportable business segments, which include, among others, consumer healthcare, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The Company's products are sold to a wide range of customers, including pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. In April 2003, the Company completed its merger with and into Pfizer. Pharmacia and Pfizer's combined operations create a research-based pharmaceutical company.
(Source: 10-K405)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
----YesYes-

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
--YesYes---

Industries
SIC Code Description
2834 Pharmaceutical preparations
2869 Industrial organic chemicals, not elsewhere classified
2833 Medicinal chemicals and botanical products
2879 Pesticides and agricultural chemicals, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Chief Executive Officer FredHassan 59 2/21/2001 4/3/2000
Chief Financial Officer, Executive Vice President Christoher J.Coughlin 49 3/1/2000 3/1/2000
Executive Vice President and President, Research and Development GoranAndo, M.D. 56 3/1/2000 3/1/2000
8 additional Officers and Directors records available in full report.

General Information
Number of Employees: 43,000 (As of 12/31/2002)
Outstanding Shares: 1,295,751,796 (As of 3/18/2003)
Shareholders: 69,346
Stock Exchange: NYSE
Federal Tax Id: 430420020
Fax Number: (908) 901-7700


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, April 11, 2024